Self-injurious Behavior Clinical Trial
Official title:
An Outpatient Phase 3 Efficacy Study of Ecopipam (PSYRX 101) in the Symptomatic Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
The purpose of this research study is to gather scientific information about the effectiveness and safety of the study drug, Ecopipam (PSYRX 101), for the treatment of self-injurious behaviors when compared with the effectiveness and safety of placebo (inactive substance) in subjects with Lesch-Nyhan Disease.
This study will be done in approximately 6 centers in approximately 4 countries, and approximately 24 subjects will be included. This study is divided into two parts. The first is a double-blinded portion lasting up to 18 weeks in total. The second portion is an optional open-label extension and lasts up to 54 weeks total. The total duration of the study, if you choose to participate in both portions, is anticipated to be up to approximately 78 weeks. The first portion of this study is double-blind and assignment to a treatment group is done randomly. In this study, there are two treatment groups. One group will receive Ecopipam for one 6-week period and placebo for two 6-week periods, and the other group will receive Ecopipam for two 6-week periods and placebo for one 6-week period. Subjects who did not experience any clinically significant side effects during the blinded portion of the study may be eligible to participate in an open-label extension that may last up to 54 weeks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02914847 -
Imaginator: a Pilot of Brief Functional Imagery Training for Self-harm
|
N/A | |
| Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
| Recruiting |
NCT00491478 -
Repetitive Behavior Disorders in People With Severe Mental Retardation
|
Phase 3 | |
| Terminated |
NCT02483572 -
Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control
|
N/A | |
| Completed |
NCT02985047 -
Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide
|
N/A | |
| Recruiting |
NCT04463654 -
Zero Self-Harm - a Mobile Phone Application to Reduce Non-suicidal Self-injury
|
N/A | |
| Completed |
NCT04244786 -
Treating Self Injurious Behavior: A Novel Brain Stimulation Approach
|
N/A | |
| Not yet recruiting |
NCT02595164 -
Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders
|
N/A | |
| Completed |
NCT00401102 -
Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury
|
Phase 1 | |
| Recruiting |
NCT06110585 -
Transcranial Magnetic Stimulation in Patients With Depression and Non-suicidal Self-injury
|
N/A | |
| Completed |
NCT05563324 -
Genetics of Self-injurious Behaviour
|
||
| Recruiting |
NCT04045600 -
Refinements of Functional Communication Training
|
N/A | |
| Recruiting |
NCT00694668 -
The (Cost-) Effectiveness of Mindfulness-training and Cognitive Behavioural Therapy in Adolescents and Young Adults With Deliberate Self Harm
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05796531 -
Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
|
N/A | |
| Terminated |
NCT01823120 -
Text Message Intervention to Reduce Repeat Self-harm
|
N/A | |
| Recruiting |
NCT00169884 -
The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients
|
Phase 2 | |
| Terminated |
NCT03980366 -
Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders
|
N/A | |
| Not yet recruiting |
NCT05969080 -
Self-Injury Treatment and Recovery in Veterans
|
N/A | |
| Recruiting |
NCT06225661 -
Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour
|
N/A | |
| Enrolling by invitation |
NCT03995966 -
A Clinical Trial for Self-Injurious Behavior
|
N/A |